Brayton Purcell LLP

Call For A Free Consultation
800-598-0314

Call For A Free Consultation 800-598-0314

Brayton Purcell LLP
  • Home
  • Firm Overview
    • Our Beliefs
      • Giving Back
      • Our Associations And Memberships
      • The Right To Trial By Jury
    • Regions Served
    • Careers
    • Our Employees Pets
    • Press Releases
  • Attorneys
  • Practice Areas
    • Mesothelioma/Asbestos
    • Personal Injury/Wrongful Death
    • Toxic Substances
    • Estate Planning
    • Other Areas Of Practice
  • Court Successes
    • Trial Verdicts
    • Appeals
  • Testimonials
  • Blog
  • Videos
  • Contact
  • Home
  • Firm Overview
    • Our Beliefs
      • Giving Back
      • Our Associations And Memberships
      • The Right To Trial By Jury
    • Regions Served
    • Careers
    • Our Employees Pets
    • Press Releases
  • Attorneys
  • Practice Areas
    • Mesothelioma/Asbestos
    • Personal Injury/Wrongful Death
    • Toxic Substances
    • Estate Planning
    • Other Areas Of Practice
  • Court Successes
    • Trial Verdicts
    • Appeals
  • Testimonials
  • Blog
  • Videos
  • Contact

In a True Cost-Benefit Analysis, Asbestos Is Simply Unaffordable

by Brayton Purcell LLP | Apr 21, 2016 | Asbestos-Related Illness

Many Americans assume that Asbestos has been completely banned in the United States. Unfortunately, that’s not the case. The dangerous material is no longer mined/produced in the U.S., but it is still used in certain construction and industrial projects.

In light of the fact that exposure to asbestos is known to cause deadly mesothelioma, why would legislators allow any new use of the material in the United States? There may be a number of answers to that question, but many believe that it comes down to economics. Asbestos has long been cheap and abundant, which is why it was so heavily used before its dangers were known. But asbestos use can no longer be justified, even from an economics perspective, according to the World Health Organization.

The results of a recent study commissioned by the WHO reveal that the costs associated with treating asbestos-related diseases are four times higher than the costs of producing the product in the first place. For every $1 spent on mining and producing asbestos, about $4 is spent treating diseases like asbestosis and mesothelioma.

According to the World Health Organization, more than 107,000 people worldwide are killed each year by exposure to asbestos in the workplace. Even more alarming, about 125 million people globally face occupational exposure to asbestos.

The WHO study makes clear that treating asbestos-related diseases costs far more than producing asbestos. But this calculation might not lead to a reduction in asbestos production unless asbestos producers are forced to pay the costs of their deadly product.

Many such companies have already gone out of business, but victims can still be compensated through asbestos trusts funds. If you or a loved one has developed a serious illness due to asbestos exposure, please contact an experienced attorney to discuss your rights and legal options.

Recent Posts

  • U.S. asbestos imports jump in 2020
  • The dangers of homes built with asbestos
  • Four jobs at risk of asbestos exposure
  • 5 Common Products You Might be Shocked to Learn Contain Asbestos
  • You never know where you will find asbestos on your property

Archives

Categories

RSS Feed

Subscribe To This Blog’s Feed

Free Consultation

Take The First Step In Resolving Your Issue. Send Us An Email.

Email Us For A Response

San Francisco
Bay Area Office

222 Rush Landing Road Novato, CA 94945

Novato Office
222 Rush Landing Road
Novato, CA 94945
Toll Free: 800-598-0314
Phone: 415-898-1555
Fax: 415-898-1247

Map & Directions

Southern California
Office

12 28th Street Venice, California 90291

Los Angeles Office
12 28th Street
Venice, California 90291
Toll Free: 800-598-0314
Phone: 415-898-1555
Fax: 415-898-1247

Map & Directions
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

© 2021 Brayton Purcell LLP. All Rights Reserved.

Disclaimer | Site Map | Privacy Policy | Business Development Solutions by FindLaw, part of Thomson Reuters

Review Us